Ozempics SELECT trial showed that patients taking semaglutide had a 20% lower risk of heart attack, stroke, or cardiovascular death compared to placebo
Image credits: Mike Marsland / Axelle/Bauer-Griffin These transformations usually result in the person looking slimmer but without the muscle tone and firmness associated with a slower, less drastic approach to weight loss via diet and exercise
Who May Be at Greater Risk of Adverse Effects Over Time Older adults, people with prior pancreatitis or gallbladder disease, those with cardiovascular conditions or diabetic retinopathy, and individuals with renal impairment face heightened risk and require closer monitoring
Both peptides are dosed weekly, but Retatrutides extended pharmacokinetic profile makes it more resilient to travel, shift work, or occasional dosing delays
For example, covering medications like Wegovy could cost health plans hundreds of millions annually for only a small portion of their members (Siskind, 2024)
(40) that GLP-1RAs may be ineffective in reducing appetite and body weight in the BBS population
